EQS-Adhoc: Correction of a release from 02/10/2025, 10:25 CET/CEST - The Platform Group AG raises its forecast for 2026 to EUR 1 billion in sales and EUR 70–80 million in EBITDA – three acquisitions in the pharmaceutical sector and expansion in the Optics & Hearing
|
EQS-Ad-hoc: The Platform Group AG / Key word(s): Expansion/Change in Forecast Correction of a release from 02/10/2025, 10:25 CET/CEST – The Platform Group AG raises its forecast for 2026 to EUR 1 billion in sales and EUR 70–80 million in EBITDA – three acquisitions in the pharmaceutical sector and expansion in the Optics & Hearing segment Correction to the second paragraph: The information regarding a shareholding and its legal company name was not presented correctly. The corrected announcement is reproduced in full below. Düsseldorf, 6 October 2025. The Management Board of The Platform Group AG (ISIN: DE000A2QEFA1) has decided to raise its medium-term forecast for the 2026 financial year. Net sales of around EUR 1.0 billion (previous forecast: over EUR 860 million) and adjusted EBITDA in a range of EUR 70 million to EUR 80 million (previous forecast: over EUR 64 million) are now expected. Gross merchandise volume (GMV) is expected to rise to around EUR 1.7 billion (previous forecast: EUR 1.6 billion). The forecast for the 2025 financial year remains unchanged. In addition to TPG's positive earnings performance and organic growth, the increase is attributable to the majority acquisition of Cologne-based Apothekia GmbH, which operates a pharmaceutical training platform. In addition, TPG holds a 50% stake in the Vienna-based Contracta Group, which owns 100% of the Austrian company Pharmosan and 79.5% of the Czech company Vamida. Furthermore, further acquisitions in the Optics & Hearing sector are taking place in October. The “Service & Retail Goods” segment will be expanded as a result and will be renamed “Pharma & Service Goods” in the future. The transactions are expected to close by the end of 2025, subject to approval by the relevant antitrust authorities. In addition, The Platform Group has entered into agreements to acquire two further companies in the “Optics & Hearing” segment. Together, these companies generate sales in the single-digit million range with an EBITDA margin of around 24%. Investor Relations End of Inside Information
06-Oct-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | The Platform Group AG |
| Schloss Elbroich, Am Falder 4 | |
| 40589 Düsseldorf | |
| Germany | |
| E-mail: | ir@the-platform-group.com |
| Internet: | https://the-platform-group.com/ |
| ISIN: | DE000A2QEFA1 |
| WKN: | A2QEFA |
| Listed: | Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Scale), Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; Oslo |
| EQS News ID: | 2208228 |
| End of Announcement | EQS News Service |
|
|
2208228 06-Oct-2025 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | ||
| Sales1 | 73,16 | 94,81 | 133,76 | 168,43 | 432,20 | 524,64 | 725,00 | |
| EBITDA1,2 | 6,77 | 5,88 | 1,59 | 14,11 | 46,75 | 55,63 | 56,00 | |
| EBITDA-Margin3 | 9,25 | 6,20 | 1,19 | 8,38 | 10,82 | 10,60 | 7,72 | |
| EBIT1,4 | 4,27 | 3,45 | -0,51 | 9,12 | 38,91 | 45,78 | 54,00 | |
| EBIT-Margin5 | 5,84 | 3,64 | -0,38 | 5,42 | 9,00 | 8,73 | 7,45 | |
| Net Profit (Loss)1 | 1,40 | 0,87 | -1,70 | 7,98 | 26,99 | 32,74 | 50,00 | |
| Net-Margin6 | 1,91 | 0,92 | -1,27 | 4,74 | 6,25 | 6,24 | 6,90 | |
| Cashflow1,7 | 1,84 | 5,24 | -13,81 | 2,22 | 104,09 | 57,99 | 65,00 | |
| Earnings per share8 | 0,23 | 0,14 | -0,27 | 1,12 | 1,48 | 1,60 | 2,40 | |
| Dividend per share8 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: Russler & Arnold
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| The Platform Group | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| A2QEFA | DE000A2QEFA1 | AG | 130,91 Mio € | 29.10.2020 | Kaufen | 9F385RGG+37 |
| PE 2026e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 2,45 | 3,58 | 0,68 | 9,79 | 0,99 | 2,26 | 0,25 |
|
Dividend '2023 in € |
Dividend '2024 in € |
Dividend '2025e in € |
Div.-Yield '2025e in % |
| 0,00 | 0,00 | 0,00 | 0,00% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 25.08.2025 | 23.05.2025 | 22.08.2025 | 14.11.2025 | 28.04.2025 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| -23,48% | -30,54% | -22,53% | -20,52% | -80,26% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
